Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly grow ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.

Britain's MHRA medical regulator in 2023 became the first in the world to approve ... tool CRISPR. NICE, which assesses whether new medical technologies can be used in the NHS, said the treatment ...

not only because this marks the first approval of a CRISPR-based gene therapy for SCD [sickle cell disease] in the NHS, but also because it offers a potentially curative treatment for eligible ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

An Oxfordshire university student is among those set to receive a "transformative" gene-therapy treatment on the NHS for ...